Related Experiment Video
Updated: Jun 3, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers
1Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan. itok@nagasaki-u.ac.jp
Abstract:
The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF-β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti-oncogenic TGF-β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This "Prospect" focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression.
Insights
RUNX3 acts as a tumor suppressor in gastrointestinal cancers by regulating cell growth and adhesion. Its inactivation by Helicobacter pylori contributes to stomach precancerous states.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RUNX3 is recognized as a tumor suppressor in gastric and other cancers.
- It functions as a transcription factor, integrating TGF-β and Wnt signaling pathways.
- RUNX3 plays a role in cell proliferation, apoptosis, and adhesion.
Purpose of the Study:
- To review the tumor suppressive functions of RUNX3.
- To explore its role in gastrointestinal cancer initiation and progression.
- To understand the link between RUNX3, Wnt, and TGF-β/BMPs signaling.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of studies on gastric carcinogenesis and other cancers.
- Investigation of RUNX3's role in mouse and human intestinal tumorigenesis.
Main Results:
- RUNX3 acts as a gatekeeper between Wnt and TGF-β/BMPs pathways.
- Loss of RUNX3 function promotes precancerous gastric conditions.
- Chronic Helicobacter pylori infection inactivates RUNX3 through various mechanisms.
Conclusions:
- RUNX3 is crucial for maintaining gastrointestinal homeostasis.
- Its inactivation is a key event in cancer development.
- Understanding RUNX3's function is vital for targeting gastrointestinal cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...